Effect of Intraperitoneal Nebulisation of Magnesium Sulphate for Analgesia Following Laparoscopic Cholecystectomy
- Conditions
- Postoperative Pain
- Interventions
- Registration Number
- NCT01542697
- Lead Sponsor
- B.P. Koirala Institute of Health Sciences
- Brief Summary
intraperitoneal nebulisation with magnesuim sulphate will reduce post operative pain and analgesic consumption in postoperative period following laparoscopic cholecystectomy.
- Detailed Description
Sixty patients undergoing laparoscopic cholecystectomy belonging to American Society of Anaesthesiologist (I-II) of age 18-65 yrs will be enrolled.Group one (n=30) will receive 1.5 gm magnesium sulphate diluted in 3ml of normal saline and group 2 (n=30) will receive 5 ml of NS.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 60
ASA I-II
history of
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Magnesium sulphate intraperitoneal nebulisation of magnesium sulphate intraperitoneal nebulisation of 1.5 gm of magnesium sulphate with 2 ml of normal saline at the end of surgery before closure normal saline intraperitoneal nebulisation of magnesium sulphate intraperitoneal nebulisation of 5 ml of normal saline after end of surgery before closure
- Primary Outcome Measures
Name Time Method number of analgesic request 24 hour time to first analgesic request is taken as duration of effective analgesia
number of analgesic request in first 24 hours were also counted
- Secondary Outcome Measures
Name Time Method VAS score first complaint of pain, 6 hrs, 12 hrs, 24 hrs Visual analogue scale is a linear 10cm scale with 0 corresponding to no pain and 10 to worst pain ever
nausea and vomiting 24 hrs respiratory rate 24 hrs sedation 24hrs
Trial Locations
- Locations (1)
routine operation theatre of BPKoirala
🇳🇵Dharan, Nepal